A massive real-world cohort of more than 1 million children aged 2–18 years reveals that those with obstructive sleep apnea are about twice as likely to receive diagnoses of influenza or COVID‑19 over five years as matched peers without OSA, with higher rates of viral pneumonia as well. Despite low absolute event rates, survival analyses confirm persistent excess risk across age strata, and adenotonsillectomy does not meaningfully attenuate infection or pneumonia risk, suggesting enduring immune dysregulation beyond mechanical obstruction. The authors propose viewing pediatric OSA as a practical “risk marker” to prioritize seasonal vaccination and closer respiratory follow-up rather than a purely structural airway problem.
Check out the full cohort analysis to decide whether your OSA pathway should automatically trigger an elevated vaccine and infection-monitoring strategy. To read more…
